Hopemark Health’s Post

Gain industry insights into prescription drug therapy affordability and accessibility with the 2023 Patient Access Survey Report. Download it today to understand how policies are impacting patient access.  https://lnkd.in/eNecq4-g #Healthcare #2023PatientAccessSurveyReport

#ICYMI: The June 2024 issue of Drug Topics spotlights important #conversations from #AXS24, the Asembia Specialty Pharmacy Summit. Experts forecast #pharmacy trends in 2025 and beyond, talk about the potential impact of the upcoming presidential #election, explore health system #sustainability, and more. https://lnkd.in/eZuk5nZj

Exciting news! PrescriberPoint now has PubMed news on our site! That's right—you can now discover the latest PubMed studies right on PrescriberPoint. Say goodbye to frustrating searches and keep up with the latest on specialty drugs via an easy-to-access feed. Just enter a drug name and instantly receive relevant PubMed news. We hope this update will streamline your access to research and updates on prescribing information, making it simpler for you to stay informed. #Medicine #HealthcareTech #PatientCare #Pharmacy #Healthcare

The Value of Patience in Pharmaceutical Care As a pharmaceutical technologist working in a community pharmacy, I often encounter a variety of patient concerns, each presenting its unique challenge. One recent experience stands out and serves as a reminder of the importance of thoroughness and patience in our profession. Just as we were about to close one evening, a familiar face walked in. A middle-aged man of 28, he had been complaining of mild back pain and discomfort when urinating for several months. Previously, he had used a dose of ciprofloxacin and a painkiller, which temporarily relieved the pain. However, three months later, the discomfort had returned. He was insistent on getting another prescription, hoping for a quick fix. But something didn't sit right with me. Instead of rushing to make the sale, I advised him to undergo a prostate test. It was a suggestion met with some hesitation, but he agreed. Unfortunately, the diagnosis came back positive for prostatitis. While this wasn't the news any of us were hoping for, it was a crucial finding. He has since started a 28-day course of Tavanic, and I'm optimistic about his recovery. This experience reaffirmed my belief in the significance of taking the time to understand and address the root cause of health issues rather than opting for immediate but temporary solutions. It’s a reminder that our role is not just to dispense medication, but to provide informed and compassionate care. 💊❤️ Here’s to hoping for a full recovery for him, and to more moments of patience and precision in our practice! 🌟 #PharmaceuticalTechnologist #PatientCare #CommunityPharmacy #Healthcare #MondayMotivation

Good news 🩵to help people not getting worse 🩵💚🩵 Alzheimer’s patients and families live in a cloud of uncertainty. It’s about to get worse! Alzheimer's disease is a brain disorder that gets worse over time. It's characterized by changes in the brain that lead to deposits of certain proteins. Alzheimer's disease causes the brain to shrink and brain cells to eventually die. Alzheimer's disease is the most common cause of dementia — a gradual decline in memory, thinking, behavior and social skills. These changes affect a person's ability to function ! About 6.5 million people in the United States age 65 and older live with Alzheimer's disease. Among them, more than 70% are 75 years old and older. Of the about 55 million people worldwide with dementia, 60% to 70% are estimated to have Alzheimer's disease. The rate of progression for Alzheimer's disease varies widely. On average, people with Alzheimer's disease live between three and 11 years after diagnosis. But some live 20 years or more. The degree of impairment at diagnosis can affect life expectancy.

The FDA has approved Zunveyl (benzgalantamine) delayed-release oral tablets for the treatment of mild to moderate dementia of the #Alzheimer type in adults. For all the latest drug news, check out our drug referential resource: https://ow.ly/yUrV50SPGAT. #DrugNews #Pharmacy #Medication

The escalating reliance on pharmaceuticals in the medical field, coupled with an aging population, has led to an unprecedented increase in medication use. With over a third of the elderly population taking more than 5 prescription drugs, a phenomenon termed polypharmacy, significant concerns arise. This poses a dual challenge, explored further in this blog by George Barnes MS, CCC-SLP, BCS-S https://buff.ly/47C3QoU Which meds do you believe have the most significant effects on your patients' swallowing experiences? 💊 #dysphagia #dysphagiatreatments #dysphagiaawareness #dysphagiatherapy

Here are the four main phases of pharmacokinetics: Absorption refers to how a drug enters the bloodstream from the administration site (e.g., orally, intravenously). Distribution: Once in the bloodstream, the drug travels to various tissues. #pharmacokinetics #pharmacy #medicine #healthcare #drugmetabolism #NPpsych #PApsych #NursePractitioner #PhysicianAssistant #AdvancedPractice #NPstudent #PAstudent #NursingSchool #MedicalSchool #HealthcareProviders

📌 It's World Multiple Sclerosis Day! 🧠 Multiple sclerosis (MS)🧠 affects millions worldwide. Let us together increase the📣 awareness on the symptoms of MS that include fatigue and movement difficulties, affecting the central nervous system. 🔬 Early diagnosis and treatment are critical. To show we care, 👨⚕️let us support patient care and 👩🔬research. Visit 🌐 www.vyuhpharma.com for more info. #WorldMSDay #MSAwareness #MultipleSclerosis #MSResearch #Healthcare #PatientCare #SupportResearch #HealthAwareness #vyuhpharma #vyuhgenics #pharmanews #pharmaceutical #healthcare #pharmaceuticalindustry

Abbott Ordered to Pay $495M for Formula Linked to NEC in Preterm Infants 🚨💰 Abbott Laboratories has been ordered to pay $495 million in damages after a jury found their specialized formula for preterm infants linked to necrotizing enterocolitis (NEC). The decision came after an Illinois child developed NEC, a serious intestinal illness. The ruling includes $400 million in punitive damages and $95 million in compensatory damages. 🏥⚖️ To read the full news, visit 👉 https://lnkd.in/d4nJdH9f  Stay updated with the latest in pharmaceutical advancements at - https://lnkd.in/dh36nZ8Y Let us know your thoughts on this issue in comments below 🗣️ #PharmaNow #pharmanews #healthcare #globalpharma #legalnews #NEC #AbbottLaboratories